.png){kind=logo}
Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Feb 24, 2023A second randomized controlled trial sponsored by JDRF also demonstrates superiority of automated insulin pump as first-in-line therapy for children with type 1 diabetesMedtronic plc (NYSE:MDT), the global leader in medical technology, today announced one-year data from the ADAPT study (n=82), the first multi-national randomized controlled study comparing the...
- Feb 16, 2023
Medtronic plc, the global leader in medical technology, today announced its participation in the upcoming 16th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD)...
Dec 9, 2022Medtronic Canada is pleased to announce Health Canada has licensed the Medtronic Extended infusion set — the first and only infusion set that can be worn for up to 7 days with Medtronic insulin...
- Nov 15, 2022Annual costs savings of insulin of up to 25% and plastic waste reduction of up to 50% with Medtronic Extended infusion set
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. launch of Medtronic Extended infusion set, the first and only infusion set labelled for up to 7-day...
Nov 1, 2022The MiniMed 780G system is the only insulin pump that automatically adjusts and corrects every five minutes to help keep sugar levels in rangeMedtronic Canada is pleased to announce that it has received a license from Health Canada for its MiniMed™ 780G system for people living with type 1 diabetes. This system with advanced hybrid...
Oct 18, 2022Medtronic plc, the global leader in medical technology, is introducing a new program called My Insights exclusively made for individuals using the MiniMed™ 770G system. Using an individual's...
Sep 1, 2022First-of-its-kind study demonstrates individuals using the Medtronic system achieved 1.4% absolute reduction in A1c and 27.6% absolute increase in Time in RangeMedtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced results from the Medtronic ADAPT study were published in The Lancet Diabetes & Endocrinology. The ADAPT study is...
Sep 1, 2022Combination of InPen™ smart insulin pen system integrated with Guardian™ 4 CGM helps people with diabetes on multiple daily injections (MDI) stay ahead of their glucose levelsi,iiToday Medtronic announced the European launch of its Smart MDI system, which combines personalized insulin dosing information from the InPen™ smart insulin pen with the power of predictive...
Aug 3, 2022Former Disney Channel Actress Shares How the Medtronic InPen™ system Helps Her Balance Demands of Dual CareerActress Jennifer Stone, best known for her role on the Disney Channel’s “Wizards of Waverly Place”, will be partnering with Medtronic Diabetes to help others living with type 1 diabetes...
Jun 4, 2022This week, Medtronic is presenting new MiniMed™ 780G system real-world data from Europe and Chile and clinical data at the American Diabetes Association (ADA) 82nd Scientific Sessions. The...